CHKA and hepatocellular carcinoma: CKI dose-dependently inhibits tumor volume, decreases the microvessel density (MVD), and improves the vascular maturity index (VMI) in HepG2 tumor bearing nude mice, and the antiangiogenic effects of CKI may be important in the treatment of HCC (Wang H. et al., 2019).